<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 75 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page74.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=75">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 75 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 75</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=75"><img src="../thumb/75.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>44 / 2020-04                                              Central Nervous System - 1.7.1 / 1.7.2 / 1.7.3 / 1.8
   Dos.adjustm.dur.treatm.course: If more levodopa reqd: Incr.dos.  Maint: Indiv.& adjust accord.to respons. Where more levodopa   Side effects: Dry mouth, blurr.vis.
   freq.&/ use an alternat. strength. If less levodopa reqd: Reduc.tot.  reqd.substit.with 1 tab of Teva Carbi-Levo 25/250 tab.3-4xdly. Incr.  Warnings and special precautions: Lact.intol., diab. mellit., sfety
   dly Stalevo dos.by decr.freq.OR decr.strength of Stalevo.  by ½-1 tab. every other day to max.8 tabs.dly.  in pregn.& lactat.not est.
   With other concom.levodopa prod: Follow max.dos. recomm.  Other concom.anti-Parkinsonism agents: Other agents with
   Discontin.of ther.& switch.pt.to levodopa/ DCC inhibit.ther   except.of levodopa alone may be cont.with poss.dos.adjustm.neces-
   without entacapone: Adjust other antiparkinson.treatm. esp.levo-  sitat. Monoamine-oxidase B inhibit. (eg. Selegiline) report.to improve
   dopa to achiev.a suffic.lev.of contr.of Parkinson.sympt.  effic in control.akines.&/or dyskines.  1.7.3  Others
   Contraindications: Pregn., lactat., sev.hepat. impairm., narr.angle   Contraindications: MAOI, narr.angle glauc., hist. of melanoma/
   glauc., susp.undiagn.skin les./ melanoma hist., phaeochromocytoma,   undiag.skin les., safety & effic.in childr. und.18 yrs.not est., safety in   AZILECT, (Cipla Medpro) Teva [P/S]
   concom.non select. monoamine oxidase inhibit (MAO-A & MAO-B),   pregn. & lactat. not est., women of child bear.age.  Rasagiline
   concom.select.MAO-A & select.MAO-B inhibit., neurolept.malign.  Side effects: Dyskines., akines., ment.chang.incl. paranoid ideat.&   Indications: Monother.of idiopath.Parkinson’s dis. or as adjunct ther.
   syndr.&/non-traumat. rhabdomyolys. hist., safety & effic.in childr.und.   psychot./psych.disords., dement., agitat., anx., confus., nightmares,   with levodopa in pts.with end of dos. fluctuat.
   18 yrs.not est., lact.intol., other entacapone contain. prod.  insomn., drowsin., aggress., delirium, atax., numbn., incr. hand. trem.,   (S4) TABS. 41/5.4.1/0781
   Side effects: Orthostat.hypotens., excess.dayt. somnol.& sudd. sleep   musc.twitch.& cramps, trismus, activat. of latent Homer’s syndr., par-  711769-001: 1 mg, 28, R761,86
   episod., dyskines., naus., dizzin., NMS, rhabdomyolys., angioed., skin   aesthes., sev. depress. with/without suicid.behav., GI disturbs. incl.   Dosage: Admin.with/without food
   reacts., hair/nail & urine discolourat., fatig., fall., weight chang., incr.  bleed., card.arrhythm., palpitat., orthostat. hypotens., bradykines.,   1 mg once dly.with/without levodopa
   dopaminerg.activ., GI disturbs., patholog. gambl./incr.libido/hypersex-  somnol., burn.sensat.of tongue, hypertens., sev.gen.choreoathetoid   Contraindications: Concom.other MAOI’s/ pethidine, mod.to sev.
   ual., psychiatr./ psychot.disords., depress.with/-out suicid. tenden.,   & dyston. movem.aft.prolong.admin., exaggerat. resp. movem.&   hepat.insuff., safety in pregn./ lactat. & childr.&lt;18 yrs.not est.
   cognit.dysfunct., irreg.heart rhythm &/ palpitat., bradykinet.episod.,   exacerbat.oculogyric.cases with postencephalit. parkinsonism, bld.  Side effects: Flu syndr., skin Ca, leucopen., allerg. react., GI disturbs.,
   GI disturbs.incl. bleed., hypertens., bld.dyscras., chest/ abdom. pain,   disords., weight gain/ loss, oed., flush., incr.perspirat., rash., hair   psych./CNS disords., headache, CVA, conjunctivit., vertigo, ang.pect.,
   dyspn., convuls., atax., numbn., incr.hand trem., musc.twitch./cramp.,   loss, discolorat.of body fluids, urin.retent./ incontin., red colour.urine   MI, anorex., abnorm.dreams, rhinit., contact dermatit., vesiculobull.
   gait abnormalit., dry mouth, bitter taste, dysphag., oed., dark.& incr.   which dark.on stand., priapism, eye disords., blepharosp, chest   rash, neck pain, arthralg., myalg., arthrit., urin.urgency, malaise, fev.,
   sweat., skin rash, urin.retent./vis.disturbs.incl. oculogyr. cris., weakn.,   pain, dyspn., weakn., fatig., faintn., malaise, headache, hoarsen.,   skin melanoma, dyskines., dyston., atax., orthostat.hypotens., teno-
   headache, malaise, stimulat., malign. melanoma, hepatit.with choles-  hot flush., sense of stimulat., neurolept. malign.syndr., malign.mela-  synovit., accid.injury prim.from falls, weight loss, rhabdomyolys., in-
   tat. feat., abnorm.LFT, bradycard., parkinsonism aggrav., dyston., hy-  noma, fall., gait abnormalit.  appropr.antidiuret.hormone secret.
   perkines., ischaem. heart dis., MI, angioed.aft.ther.init.  Special precautions: Dyskines.poss.when prev. treat.with levo-  Warnings and special precautions: Avoid concom. fluoxetine/
   Warnings and special precautions: Levodopa is excret.in breast   dopa alone, the occur.of dyskines. may req.dos.reduct., teratogenic.  fluvoxamine, allow 5 wks.aft. discont. fluoxetine bef.init.Azilect ther.,
   milk, not recomm.in drug induc. extrapyramid. reacts., ischaem.heart   in experiment. anim, excret.in breast milk., discont.levodopa mono-  14 days interv. aft.discont. Azilect bef.init.fluoxetine/ fluvoxamine
   dis., sev.CV/ pulm. dis., bronch.asthma, ren./hepat./endocr.dis., pept.   ther. 12 hrs./24 hrs.for slow rel.formulat.bef. init., not recomm.for   ther., concom.dextromethorphan/ sympathomimet. as in nas.& oral
   ulc.dis.hist., convuls., MI hist.with resid.atrial nodal/ ventric.arrhythm.  drug-induc.extrapyramid. reacts., open-angle glauc., CV/pulm. dis.,   decongest./cold meds. contain.ephedr./pseudoephedr.not recomm.,
   with card.funct.monit.esp. dur. init.dos.adjustm.per., monit.for ment.  bronch. asthma, ren./hepat./endocr.dis., hist.of gastr./ duod.ulcerat.,   concom. SSRI’s/tricycl.& tetracycl.antidepress./ potent CYP1A2 in-
   chang., depress. with suic./ser.antisoc.behav., past/curr. psychos.,   MI hist., monit.card.funct.esp.dur. init. dos.adjustm., convuls., chron.  hibit, suspic.skin les.to be eval.by special. as Parkinson’s dis.assoc.
   monit.caref.with concom. antipsychot. with dopamine-recept.block.  wide-angle glauc., diabet./hypoglycaem., psychiatr.disturbs./ psy-  with high.skin Ca risk, discont.ther.if progress.from mild to mod. hepat.
   propert.partic.D 2 recept. antagon., chron.wide angle glauc.where IOP   chot. states, period.eval.of hepat./ haematopoiet./ CV & ren.funct.,   impairm., concom dextromethorph.not recomm.
   well-contr., concom.meds.caus. orthostat. hypotens., somnol.& sudd.  sev.involunt. movem. hist., abrupt withdr.  Drug interactions: Interacts. report.with MAOI’s & other select.
   episod.of sleep onset report., poss.dos.adjustm.of other antiparkins.   Drug interactions: Poss.postur.hypotens.with antihypertens., hy-  MAO-B inhibit.& sympathomimet., ser. advers. reacts.report.with
   meds. when introd.to pts.not curr.treat.with entacapone, hepat.im-  pertens/dyskines.with TCA’s, phenothiaz.& butyrophenones reduc.  SSRI’s/tricycl.& tetracycl. antidepress.and MAOI’s & other select.
   pairm., sev.ren.funct. impairm., switch.pts.to levodopa/DDC inhibit.   effs., phenytoin & papaverine reverse anti-parkin.eff., high protein diet   MAO-B inhibit., plasma lev.poss.decr.in smok.pts., entacapone incr.
   without entacapone, concom.meds.metabolis.by COMT/ prod.releas.  impair.absorpt., MAOI’s to be discont.at least 2 wks.prior.to init.ther.  clear., poss.hypertens.cris.with other MAOI’s, ser.reacts.with pethi-
   catecholamin., gen.anaesthes., progress. anorex./asthen./weight decr.  dine report.with MAOI’s & other select.MAO-B inhibit., interacts.
   with.short time, control INR for pts.receiv.warfar., concom. TCA’s/ no-  report. with non select. MAOI’s & dextromethorphan, incr.AUC with
   radren.re-uptake inhibits./meds metab.by COMT, do not exceed con-  ciprofloxacin, potent CYP1A2 inhibit.poss.alt.plasma lev.
   com.selegiline dly.dos.of 10 mg, 2-3 hr.interv.betw.Fe preps., absorpt. 1.7.2  Anticholinergics
   poss. imp. by high prot.diet., withdr.slow.when consid. necesss., treatm.  COMTAN, Novartis [P/S]
   init.in an entacapone naive pt., abrupt entecapone & other dopamin-  AKINETON, Pharmaco [P/S]  Entacapone
                                                              Indications: Adjunct to standard levodopa/ benzerazide or levo-
   erg.reduct./ discont., monit.pts.on concom.neurolept.caref.if withdr./   Biperiden HCl
   abrupt.dos.reduct., viscer.& skelet. malformat. in rabbits, per.hepat./  Indications: Parkinson., drug-induc.extrapyramid. sympt., spast.,   dopa/carbidopa Parkinson dis. & end-of-dos. motor fluctuat.not sta-
                                                              bilis.on these combinat.
   haematopoiet./ CV/ ren.funct.eval.dur.extend.ther., monit.weight &   cranio cerebr.trauma, trigem. neuralg., nicotine poison., bronchosp.
   discont.ther.in case of prolong./persist.diarrh., poss. incr.prostate Ca risk.  (S4) TABS, [P/S] B1042  (S4) TABS, 32/5.4.1/0684
                                                              868590-002: 200 mg, 100, R1 313,21
   Drug interactions:. Poss.postur.hypotens.with anti-hypertens., do-  701491-019: 2 mg, 50, R189,10
   pamine recept.antagon./ phenytoin & papaverine may reduc.levodopa   701491-027: 2 mg, 500, R1 890,90  Dosage: 200 mg in combinat.with each levodopa / dopa decarboxy-
                                                              lase inhibit.dos. Max. recomm.dos. 200 mg 10xdly.
   therap. eff., metabol.of meds.contain.catech.group interfer.with & act.  Dosage: Parkinson. Adults: ½-2 tabs.3-4xdly.
   potent., metabol.of drugs. depend. on cytochrome P4502C9 poss.in-  Drug induc.extrapyramid.sympt: Admin. concom.with neuro-  To reduc.levodopa-relat.dopaminerg.adverse effs. adjust.levodopa
                                                              dos.within first few days/ wks.by about 10-30% by extend.dos.in-
   terfer. with, R-warfar.AUC incr.  lept.drug. Adults: ½-1 tab.1-4xdly.to max. 9 tabs.dly. Childr.3-15
                                yrs: ½-1 tab. 3xdly.          terv./ reduc. the amnt.of levodopa/dos. May be used with selegline
   SYMMETREL, Novartis [P/S]    Spast: Adults: Grad.incr.½ tab.2-3xdly.to 2 tabs. 3xdly. Childr.1-5 yrs:   provid.dly.dos.not exceed.10 mg.
   Amantadine HCl.              ¼-½ tab.1-3xdly. 6-11 yrs: ½-1 tab.1-6xdly. 12-16 yrs: 1 tab.2-6xdly.  Contraindications: Liv.impairm., phaeochromocyt., concom.non-
   Indications: Parkinson’s dis., symptomat. Parkinson.  Clos.cranio cerebr.trauma: Adults: Once oral medicat.poss.   select.MAO-A & MAO-B inhibits., concom.select. MAO-A inhib-
   (S4) CAPS. A/20.2.8/768.     1-2 tabs.3-5xdly.x5-9 wks. Mild sympts: 1 tab.3xdly.x2-3wks. Childr:   its. & select. MAOI-B inhibit., neurolept.malign. syndr. hist.and/or
   768243-009: 100 mg, 20, R339,07  ½-2 tabs. 3xdly. Mild: ½-1 tab. 3xdly.  non-traumat.rhabdomyolys., safety in pregn.& lactat.not est., use in
   Dosage: Admin.with meals pref.in morn.& midd. Admin.alone for   Trigem.neuralg: 1-2 tabs.3xdly.x2 mnths.  childr. und. 18 yrs.not recomm., fruct.intol./gluc.-galact. malabsorpt./
   init.ther./combin.with anticholin./ levodopa  (S4) INJ, [P/S] B1039.   sucrose-isomaltase insuffic,
   Parkinsons: Init. 1 cap dly.for 4-7 days or max.2 wks. Maint: 1 cap   Biperiden lactate  Side effects: Hypertherm., GI disturbs.incl.colit., dyskines., dry
   2xdly Max: 1 cap 3xdly.      701505-001: 5 mg/ml, 5x1 ml, R269,00  mouth, insomn., hallucinat., confus., paroniria, agitat., Parkinson.
   Contraindications: Pregn., lactat., confus., hallucinat. or epileptif.  Dosage: Parkinson. Adults: 10-20 mg IM/slow IV dly.spread   aggrav., dizzin., dyston., hyperkines., headache, trem., vertigo, leg
   states, sev.ren./hepat.dis., childr.&lt;5 yrs.  over the day.  cramps, hepatit.with cholestat. features, postur.hypotens., urin.dis-
   Side effects: Incr.seiz.freq., depress., anx., mood elev., agitat., nerv-  Drug induc.extrapyramid.sympt: 2,5-5 mg slow IV/IMI. Childr.  ords., fatig., incr. sweat., fall, decr.Hb, bld.dyscras., skin disords., ur-
   ousn., hallucinat., nightmares, confus., disorientat., psychot.disord.,   upto 1yr: 1 mg. Upto 6 yrs: 2 mg. Upto 10 yrs: 3 mg slow IV.  ticar., skin/hair/beard & nail discolourat. weight decr.
   delirium hypoman.state, mania, CNS effs.incl.dyskines., convuls.,   Spast: Adults: 5 mg IMI 2-3xdly.  Special precautions: Rhabdomyolys.second.to sev. dyskines./
   NMS-like sympt., periph./ankle oed., livedo reticularis, palpit., or-  Clos.cranio cerebr.trauma, unconsciousn: 5-20 mg IV until   neurolept.malign.syndr.report.in Parkinson pts.when dopaminerg.
   thostat.hypotens., card. insuff./fail., leucopen., GI eff., skin reacts.   respons.then 15-60 mg/24 hrs. Add to continuous IV drip. Childr:   meds.withdr. abrupt., grad.withdr., concom.meds.caus. orthostat.
   incl. diaphores.& photosens., ocul.effs.incl. corn. epithel. oed.& vis.  1,25-5 mg several times if necess.till consciousn.improv. Transf.to   hypotens., undesir.dopaminerg.effs. more common with concom.
   acuity, urin.retent./incont.  oral med.as soon as poss.    dopamine agonists, adjust. other antiparkinson.meds.when treatm.
   Warnings and special precautions: Caref. monit. other anti-  Trigem.neuralg: 2,5-5 mg/day slow IV then 5 mg IM x10 days   initiat., admin.entacapone & iron preps.2-3 hrs. apart., INR monitor.
   parkinson.agents & epilept., incr. hallucinat./ confus.& nightmare   then transf.to oral ther.  with concom.warfarin, excret. in breastmilk, excess.daytime som-
   poss,with concom. anticholin./ underly.psychiatr.disords., pts.at-  Nicotine poisoning: In addit.to convent. therapeut. meas. 5-10 mg   nol.& sudd. sleep, weight monit.advis.in pts.with excess. diarrh.,
   tempt. suic., emergence of cross-resist.virus., no stimul. agents (eg   IMI or in threaten. emerg. 5 mg IV.  concom.TCA’s/noradren.re-uptake inhibits./ concom.meds.metabol.
   sympathomimet./appetite-depress.must be giv., early pregn., adeq.  Bronchosp.dur.bronchorespirometry: 5-10 mg IV.  by COMT, observ. prec.valid for levodopa ther., pathologic. gambling/
   meas.to prev.pregn., CCF, sev.ren./hepat.dis., recurr.eczema, gastr.   Contraindications: Narr.angle glauc., GIT mechan. stenos.,   incr.libido & hypersexuality in assoc. with levodopa
   ulcerat., CV disords., effic.may be lost within few. mnths. contin.  megacolon.  Drug interactions: Levodopa effs.enhanc., pharmacokinet. of meds.
   treatm., reduc.grad.to avoid exacerbat. of Parkinson, monit.pts.with   Side effects: Dry mouth, accomodat.disords., dizzin., fatig., ver-  metabol. by COMT poss. influenc., chelat.format.with Fe in GIT, act. of
   pre-exist. seiz. disords.    tigo, gastr.upset., incr.heart rate, feel.of unrest., anur., micturit.dis-  meds.contain.a catechol group poss.potent., incr. levodopa bioavail.
   Drug interactions: Incr.atropine-like S/E with anticholinerg.agents   turbs. Inj.also: Decr.BP  from levodopa/ benserazide preps.
   & levodopa, psychot. decompensat. with concom.neurolept.med./   Special precautions: Tachycard.condits., incr. tenden.to convuls.  STALEVO, Novartis South Africa (Pty) Ltd
   levodopa, incr.CNS toxic.with CNS-acting substanc. & alcoh., clear.  Drug interactions: Anti-parkinson drugs, quinidine, TCA’s poss.  See Section 1.7.1
   reduc.by hydrochlorothiaz. & K-spar.diurets.  intensificat.of centr.effs.
   TEVA CARBI-LEVO, (Cipla Medpro) Teva [P/S]  DISIPAL, iNova [P/S]
   Carbidopa 25 mg, levodopa 100(250) mg.  Orphenadrine HCl          Anti-vertigo and
   Indications: Parkinson.dis.& syndr.  Indications: Parkinson.& pre-Parkinson., senile & pre-senile de- 1.8
   (S4) TABS. 32/5.4.1/0081, 0024.  press., neurolept.syndr
   710286-001: 25/100 mg, 100, R346,67  (S4) TABS, C764              anti-emetic agents
   710468-001: 25/250 mg, 100, R477,76  720542-006: 50 mg, 100, R99,89
   Dosage: Titrate dos. Pts.not receiv.levodopa: Init 1 tab of Teva   Dosage: Parkinson; Neurolept.syndr: 1-2 tabs 3-4xdly.  ACULOID, (Cipla) Pharmascript [P/S]
   Carbi-Levo 25/100 tab 3x/day. Incr.dos.by 1 tab.dly/on alt.days as   Pre-Parkinson., senile & pre-senile depress: 1 tab 2xdly.  Cyclizine HCl.
   necess. Teva Carbi-Levo 25/250: Init dos: ½ tab.2xdly.incr.by ½ tab.  Neurolept.syndr: Up to 3 tabs 3xdly.  Indications: Prevent.& treatm.of N&V & motion sickn., vertigo &
   dly./on alt. days as necess. Carbidopa dos. not to exceed 200 mg dly.  Contraindications: Glauc., prostat.hypertrophy.  labyrinth.disords.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page74.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page70.html">70</a>&nbsp;&nbsp;&nbsp;<a href="page71.html">71</a>&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>
             </td>
             <td width="35%"><a href="page76.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page76.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
